Recent Company News

• 07:50 AM ET Oct 06, 2026
  

  Healthcare, banks, media and food/beverage the best performers; energy the notable laggard:

• 02:54 AM ET Oct 06, 2026
  

  StreetAccount Summary - European pre-market trading update

• 01:46 AM ET Oct 06, 2026
  

  Respighi BidCo SpA increases offer consideration to €53.00 per Recordati share from €51.29; extends acceptance period until 23-Oct-26 (€52.20, 0.00)

• 01:01 PM ET Sep 18, 2026
  

  StreetAccount Activist Summary: Week of 14-Sep

• 12:08 PM ET Sep 13, 2026
  

  Recordati holders unhappy with CVC's take-private bid - FT (€52.00, 0.00)

• 10:34 AM ET Sep 04, 2026
  

  Zanvastro price $1.14M per patient year WAC - conf. call ($58.01, -0.12)

• 07:49 PM ET Sep 03, 2026
  

  Ionis Pharmaceuticals issues press release on FDA approval of Zanvastro (zilganersen) injection for Alexander disease ($58.13, 0.00)

• 03:54 PM ET Sep 03, 2026
  

  FDA approves Zanvastro (zilganersen) injection for Alexander disease ($57.73, -3.60)

• 09:45 AM ET Jul 29, 2026
  

  Transcript Intelligence: Recordati Q2 Earnings Guidance

• 09:45 AM ET Jul 29, 2026
  

  Transcript Intelligence: Recordati Q2 Earnings Q&A